Atlantic Pathology goes live with Techcyte SureView for Pap test quality control

Atlantic Pathology in Puerto Rico has deployed Techcyte SureView for AI-assisted quality control of ThinPrep Pap tests. The move comes as the island faces one of the highest cervical cancer incidence rates in the U.S. and expands Atlantic Pathology’s broader digital pathology plan with Techcyte.

Why it matters: - Puerto Rico has a cervical cancer burden that makes cervical cytology quality control especially important for women’s health care. - A recent JAMA Network Open study reported 11.5 cervical cancer cases per 100,000 women in Puerto Rico, compared with 7.5 nationally. - Atlantic Pathology’s adoption of AI-assisted QC adds a digital review layer to Pap test workflows used across the island.

What happened: - Techcyte announced that Atlantic Pathology has gone live with the Techcyte SureView Cervical Cytology System. - The system is being used for AI-assisted quality control of ThinPrep Pap tests. - Atlantic Pathology is headquartered in Manatí, Puerto Rico. - The laboratory serves healthcare providers across Puerto Rico, including San Juan and Arecibo.

The details: - Techcyte SureView combines whole slide imaging, AI-assisted analysis and review tools for Pap test workflows. - Atlantic Pathology digitizes slides on a Hamamatsu S360 scanner before assessment in the platform. - Atlantic Pathology has integrated its internally developed LIS into Techcyte Fusion. - Atlantic Pathology is also working with Techcyte to implement Techcyte Fusion AP, the company’s anatomic pathology platform. - The Techcyte SureView Cervical Cytology System and Fusion AP are for research use only in the U.S. - The SureView Cervical Cytology System is CE-IVDD marked in the E.U. - Fusion AP is CE-IVDR certified in the E.U. - ThinPrep is a registered trademark of Hologic, Inc.

Between the lines: - The deployment signals a step from conventional slide review toward more digitized pathology operations. - Techcyte described the SureView rollout as a practical first step in a broader digital pathology strategy. - The partnership also suggests Atlantic Pathology wants its QC workflow and lab systems to work more closely together through a shared digital platform.

What’s next: - Atlantic Pathology and Techcyte are continuing work on the broader rollout of Techcyte Fusion AP. - The companies did not give a timeline for further implementation. - Techcyte says it will continue supporting Atlantic Pathology as the laboratory expands its digital pathology use.

The bottom line: - Atlantic Pathology is using Techcyte SureView to add AI-assisted quality control to cervical cytology in a market where the public health need is clear and the digital pathology stack is still expanding.